Langlara Insulin Glargine Biosimilar Approved: What This New, More Affordable Lantus Alternative Means for Your Diabetes Care
Langlara is a newly approved interchangeable insulin glargine biosimilar that offers a lower-cost alternative to Lantus. Discover its benefits, safety profile, dosing details, and what switching could mean for people with type 1 and type 2 diabetes in the United States.
